Botulinum toxin type A for pain control in temporomandibular joint disorder patients
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20243448Keywords:
Temporomandibular joint disorders, Botox, Fillers, Hyaluronic acid, BTX-AAbstract
Temporomandibular disorders (TMDs) include different conditions, such as: myofascial pain that involves discomfort or pain in the muscles that control jaw function, also internal derangement of the jaw involves a displaced disc, or injury to the condyle, and arthritis that refers to a group of degenerative/inflammatory joint disorders, the causes of TMDs is multifactorial; it includes occlusal factors such as bruxism, stress and psychological status, hormonal factors, and systemic diseases, treatment encompasses simple treatment for example physiotherapy, intra-oral appliance, certain medications, as well as complex treatment such as intra-articular injection and surgery. Botox is considered a peripheral muscle relaxant and a very effective option to reduce pain with TMD patients. Consequently, the present review article was undertaken to shed some light on the different treatment modalities of TMDs and specifically the relevance of botulinum toxin type A (BTX-A) for pain relief in TMD patients. Searches were conducted in Medline (via PubMed, Scopus, The Cochrane library), all original relevant studies that discussed the effectiveness of BTX-A in managing temporomandibular disorders were included. BTX-A injection in masticatory muscles of patients with TMD can be a useful supportive therapy to control pain and improve quality of life.
Metrics
References
González-Sánchez, B.; García Monterey, P.; Ramírez-Durán, M.d.V.; Garrido-Ardila, E.M.; Rodríguez-Mansilla, J.; Jiménez-Palomares, M. Temporomandibular Joint Dysfunctions: A Systematic Review of Treatment Approaches. J. Clin. Med. 2023; 12: 4156. https:// doi.org/10.3390/jcm12124156 https://pubmed.ncbi.nlm.nih.gov/31869076/
Thambar S, Kulkarni S, Armstrong S, Nikolarakos D. Botulinum toxin in the management of temporomandibular disorders: a systematic review. Br J Oral Maxillofac Surg. 2020;58(5):508-519. doi: 10.1016/j.bjoms.2020.02.007. Epub 2020 Mar 3. PMID: 32143934.
la Fleur P, Adams A. Botulinum Toxin for Temporomandibular Disorders: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020; Feb 25.
Christidis, N., Al-Moraissi, E.A., Barjandi, G. et al. Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis. Drugs. 2024;84: 59–81. https://doi.org/10.1007/s40265-023-01971-9
Peck, C.C., Goulet, J.-P., Lobbezoo, F., Schiffman, E.L., Alstergren, P., Anderson, G.C., de Leeuw, R., Jensen, R., Michelotti, A., Ohrbach, R., Petersson, A. and List, T. Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders. J Oral Rehabilitation. 2014, Jan;41(1):2-23. doi: 10.1111/joor.12132. PMID: 24443898; PMCID: PMC4520529.
Freesmeyer WB, Fussnegger MR, Ahlers MO. Diagnostic and therapeutic-restorative procedures for masticatory dysfunctions. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2005; 4:1–29
The Academy of Prosthodontics. The glossary of prosthodontics terms 8th edition. J Prosthet Dent. 2005; 94:10–92
Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. CRANIO. 2008; 26:126–135
Cairns BE. Pathophysiology of TMD pain – basic mechanisms and their implications for pharmacotherapy. J Oral Rehabil. 2010; 37:391–410
Razmaitė A, Trakinienė G. The effect of botox for the correction of the gummy smile: A systematic review. Stomatologija. 2021;23(3):63-68. PMID: 35319495
Ramos-Herrada RM, Arriola-Guillén LE, Atoche-Socola KJ, Bellini-Pereira SA, Castillo AA. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review. Dent Med Probl. 2022 Apr-Jun;59(2):271-280. doi: 10.17219/dmp/145759. PMID: 35775414.
Dimitroulis G. Temporomandibular disorders: a clinical update. BMJ. 1998 Jul 18;317(7152):190-4. doi: 10.1136/bmj.317.7152.190. PMID: 9665905; PMCID: PMC1113540.
Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. PMID: 25822556.
Robinson JL, Johnson PM, Kister K, Yin MT, Chen J, Wadhwa S. Estrogen signaling impacts temporomandibular joint and periodontal disease pathology. Odontology. 2020 Apr;108(2):153-165. doi: 10.1007/s10266-019-00439-1. Epub 2019 Jul 3. PMID: 31270648; PMCID: PMC7192637.
Mustafa MA, Al-Attas BA, Badr FF, Jadu FM, Wali SO, Bawazir YM. Prevalence and Severity of Temporomandibular Disorders in Rheumatoid Arthritis Patients. Cureus. 2022 Jan 15;14(1):e21276. doi: 10.7759/cureus.21276. PMID: 35070578; PMCID: PMC8761059.
Sanders AE, Maixner W, Nackley AG, et al. Excess risk of temporomandibular disorder associated with cigarette smoking in young adults. J Pain. 2012;13(1):21-31
Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res. 2018 Mar 16; 11:571-587. doi: 10.2147/JPR.S127950. PMID: 29588615; PMCID: PMC5859913.
Wang X, Yang Y, Lin L, Yao Q, Zhang J. Obesity and temporomandibular joint disorders: a systematic review and meta-analysis. BMC Oral Health. 2023 Aug 29; 23(1):607. doi: 10.1186/s12903-023-03322-2. PMID: 37644424; PMCID: PMC10466750.
Kim, H. S., Yun, P. Y., & Kim, Y. K. A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofacial plastic and reconstructive surgery. 2016;38(1): 5. https://doi.org/10.1186/s40902-016-0051-7
Ataran, R., Bahramian, A., Jamali, Z., Pishahang, V., Sadeghi Barzegani, H., Sarbakhsh, P., & Yazdani, J. The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review. Journal of dentistry (Shiraz, Iran) 2017; 18(3): 157–164.
Calis, S., A., Colakoglu, Z., & Gunbay, S. The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders. Journal of stomatology, oral and maxillofacial surgery. 2019; 120(4):322–325. https://doi.org/10.1016/j.jormas.2019.02.015
Loster JE, Wieczorek A. An assessment of the effectiveness of treatment for temporomandibular joint dysfunctions. Dent Med Probl. 2014; 51:72–78
Dimitroulis G. Temporomandibular joint surgery: what does it mean to the dental practitioner? Aust Dent J 2011; 56:257–264
Dimitroulis G. The role of surgery in the management of disorders of the temporo-mandibular joint: a critical review of the literature; Part 2. Int J Oral Maxillofac Surg 2005; 34:231–273.
Garefis P, Grigoriadou E, Zarifi A, Koidis PT. Effectiveness of conservative treatment for craniomandibular disorders: A 2-year longitudinal study. J Orofac Pain 1994;8(3):309–14.
Indresano A, Alpha C. Nonsurgical management of temporomandibular joint disorders. In: Fonseca RJ, Marciani RD, Turvey TA, editors. Oral and maxillofacial surgery. 2nd edn. St. Louis, MO: Saunders/Elsevier, 2009; p. 881–97.
Kijak E, Lietz-Kijak E, Śliwiński Z, Frączak B. Muscle activity in the course of rehabilitation of masticatory motor system functional disorders. Postepy Hig Med Dosw. 2013; 67:507–516
Ebrahim S, Montoya L, Busse JW, et al. The effectiveness of splint therapy in patients with temporomandibular disorders. A systematic review and meta-analysis. J Am Dent Assoc. 2012; 143: 847–857.
Hamata MM, Zuim PRJ, Garcia AR. Comparative evaluation of the efficacy of occlusal splints fabricated in centric relation or maximum intercuspidation in centric relation or maximum intercuspidation in temporomandibular disorders patients. J Appl Sci. 2009; 17:32–38
Ash MM Jr, Ramfjord SP. Reflections on the Michigan splint and other intraocclusal devices. J Mich Dent Assoc. 1998; 80:32–35, 41–46
LeResche L, Mancl LA, Drangsholt MT, Huang G, Von Korff M. Predictors of onset of facial pain and temporomandibular disorders in early adolescence. Pain. 2007; 129:269–278
Glaros AG, Williams K, Lausten L. The role of parafunctions, emotions, and stress in predicting facial pain. JADA. 2005; 136:451–458
Miernik M, Wieckiewicz M, Paradowska A, Wieckiewicz W. Massage therapy in myofascial TMD pain management. Adv Clin Exp Med. 2012; 21:681–685
van Grootel RJ, Buchner R, Wismeijer D, et al. (2017) Towards an optimal therapy strategy for myogenous TMD, physiotherapy compared with occlusal splint therapy in an RCT with therapy-and-patient-specific treatment durations. BMC Musculoskeletal Disord. 2017; 18: 76.
Samiee A, Sabzerou D, Edalatpajouh F, et al. Temporomandibular joint injection with corticosteroid and local anesthetic for limited mouth opening. J Oral Sci. 2011; 53: 321–325.
Hatayama T, Kitamura S, Tamura C, Nagano M, Ohnuki K.The facial massage reduced anxiety and negative mood status and increased sympathetic nervous activity. Biomed Res. 2008; 29:317–320
Wieckiewicz M, Paradowska A, Kawala B, Wieckiewicz W. SAPHO syndrome as a possible cause of masticatory system anomaly – a review of the literatue. Adv Clin Exp Med. 2011; 20:521–525
Kimos P, Biggs C, Mah J, et al. Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial. Pain. 2007; 127: 151–160.
Hersh EC, Balasubramaniam R, Pinto A. Pharmacologic management of temporomandibular disorders. Oral Maxillofac Surg Clin N Am. 2008;20(2):197-210.
Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in Temporomandibular Disorders: A Review. J Can Dent Assoc. 2017 Jul;83:h7. PMID: 29513209.
Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. J Orofac Pain. 1997;11(2):139-46.
Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED, Ambrosano GM, de Barbosa JR. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio. 2003;21(3):221-5.
Kreisberg MK. Tricyclic antidepressants: analgesic effect and indications in orofacial pain. J Craniomandib Disord. 1988 Fall;2(4):171-7. PMID: 3076592.
Wozniak K, Piatkowska D, Lipski M, Mehr K. Surface electromyography in orthodontics – a literature review. Med Sci Monit. 2013; 19:416–423
Gunson MJ, Arnett GW. Condylar resorption, matrix metalloproteinases, and tetracyclines. RWISOJ. 2010; 2:37–44
List T, Tegelberg A, Haraldson T, Isacsson G. Intra-articular morphine as analgesic in temporomandibular joint arthralgia/osteoarthritis. Pain. 2001;94(3):275-82.
Haas DA. An update on analgesics for the management of acute postoperative dental pain. J Can Dent Assoc. 2002 Sep;68(8):476-82. PMID: 12323103.
Castro WH, Gomez RS, Da Silva Oliveira J, et al. Botulinum toxin type A in the management of masseter muscle hypertrophy. J Oral Maxill Surg. 2005; 63: 20–24. 55.
Ciocia L, Donati D, Ragazzini S, Dozza B, Rossi F, Fantini M et al. Mesenchymal Stem Cells and Platelet Gel Improve Bone Deposition within CAD-CAM Custom-Made Ceramic HA Scaffolds for Condyle Substitution. Biomed Res Int. 2013;10: 1155 doi:10.1155/2013/549762.
Speculand B. Current status of replacement of the temporomandibular joint in the United Kingdom. Br J Oral Maxillofac Surg. 2009; 47:37–41
Sidebottom AJ, Gruber E. One-year prospective outcome analysis and complications following total replacement of the temporomandibular joint with the TMJ Concepts system. Br J Oral Maxillofacial Surg. 2013; 51:620–624
Gerbino G, Bianchi SD, Bernardi M, Berrone S. Hyperplasia of the mandibular coronoid process: long-term follow-up after coronoidotomy. J Craniomaxillofac Surg. 1997; 25:169–173
Abrahamsson C, Henrikson T, Nilner M, Sunzel B, Bondemark L, Ekberg EC. TMD before and after correction of dentofacial deformities by orthodontic and orthognathic treatment. Int J Oral Maxillofac Surg. 2013; 42:752–758
Derwich, M., Mitus-Kenig, M., & Pawlowska, E. Mechanisms of Action and Efficacy of Hyaluronic Acid, Corticosteroids and Platelet-Rich Plasma in the Treatment of Temporomandibular Joint Osteoarthritis-A Systematic Review. International journal of molecular sciences. 2021; 22(14): 7405. https://doi.org/10.3390/ijms22147405
Xu, J., Ren, H., Zhao, S., Li, Q., Li, C., Bao, G., & Kang, H. (2023). Comparative effectiveness of hyaluronic acid, platelet-rich plasma, and platelet-rich fibrin in treating temporomandibular disorders: a systematic review and network meta-analysis. Head & face medicine. 2023; 19(1): 39. https://doi.org/10.1186/s13005-023-00369-y
Agostini, F., Ferrillo, M., Bernetti, A., Finamore, N., Mangone, M., Giudice, A., Paoloni, M., & de Sire, A. (2023). Hyaluronic acid injections for pain relief and functional improvement in patients with temporomandibular disorders: An umbrella review of systematic reviews. Journal of oral rehabilitation. 2023; 50(12): 1518–1534. https://doi.org/10.1111/joor.13571
Xu, J., Ren, H., Zhao, S., Li, Q., Li, C., Bao, G., & Kang, H. (2023). Comparative effectiveness of hyaluronic acid, platelet-rich plasma, and platelet-rich fibrin in treating temporomandibular disorders: a systematic review and network meta-analysis. Head & face medicine, 19(1), 39. https://doi.org/10.1186/s13005-023-00369-y
Miglani, A., Vishnani, R., Reche, A., Buldeo, J., & Wadher, B. (2023). Hyaluronic Acid: Exploring Its Versatile Applications in Dentistry. Cureus, 15(10), e46349. https://doi.org/10.7759/cureus.46349
Multidisciplinary Rehabilitation after Hyaluronic Acid Injections for Elderly with Knee, Hip,
Shoulder, and Temporomandibular Joint Osteoarthritis
Parlawar, A. N., & Mundada, B. P. (2023). Enhancing Pain Relief in Temporomandibular Joint
Arthrocentesis: Platelet-Rich Plasma and Hyaluronic Acid Synergy. Cureus, 15(9), e45646.
https://doi.org/10.7759/cureus.45646
Chęciński, M., Sikora, M., Chęcińska, K., Nowak, Z., & Chlubek, D. (2022). The Administration of
Hyaluronic Acid into the Temporomandibular Joints' Cavities Increases the Mandible's Mobility: A
Systematic Review and Meta-Analysis. Journal of clinical medicine, 11(7), 1901.
https://doi.org/10.3390/jcm11071901
Cardoneanu, A., Macovei, L. A., Burlui, A. M., Mihai, I. R., Bratoiu, I., Rezus, I. I., Richter, P.,
Tamba, B. I., & Rezus, E. (2022). Temporomandibular Joint Osteoarthritis: Pathogenic Mechanisms
Involving the Cartilage and Subchondral Bone, and Potential Therapeutic Strategies for Joint
Regeneration. International journal of molecular sciences, 24(1), 171.
https://doi.org/10.3390/ijms24010171
Derwich, M., Mitus-Kenig, M., & Pawlowska, E. (2021). Mechanisms of Action and Efficacy of
Hyaluronic Acid, Corticosteroids and Platelet-Rich Plasma in the Treatment of Temporomandibular
Joint Osteoarthritis-A Systematic Review. International journal of molecular sciences, 22(14),
https://doi.org/10.3390/ijms22147405
Brin M. Botulinum toxin therapy: basic science and overview of other therapeutic applications. Management of facial lines and wrinkles. First ed. Philadelphia: Lippincott Williams & Wilkins; 2000; pp. 279–302.
Aquilina P, Vickers R, McKellar G. Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A. Br J Oral Maxillofac Surg. 2004; 42: 272–273.
Rady, N. A., Bahgat, M. M., & Abdel-Hamid, A. M. (2022). Promising minimally invasive treatment modalities for symptomatic temporomandibular joint disc displacement with reduction: a randomized controlled clinical trial. BMC oral health. 2022; 22(1):547. https://doi.org/10.1186/s12903-022-02579-3
Rezazadeh, F., Esnaashari, N., Azad, A., & Emad, S. (2022). The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study. BMC oral health. 2022; 22(1): 217. https://doi.org/10.1186/s12903-022-02220-3
Park KS, Lee CH, Lee JW. Use of a botulinum toxin A in dentistry and oral and maxillofacial surgery. J Dent Anesth Pain Med. 2016 Sep;16(3):151-157. doi: 10.17245/jdapm.2016.16.3.151. Epub 2016 Sep 30. PMID: 28884147; PMCID: PMC5586551.
Persaud R, Garas G, Silva S, Stamatoglou C, Chatrath P, Patel K. An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. JRSM Short Rep. 2013 Feb;4(2):10. doi: 10.1177/2042533312472115. Epub 2013 Feb 12. PMID: 23476731; PMCID: PMC3591685.
Castro WH, Gomez RS, Da Silva Oliveira J, et al. Botulinum toxin type A in the management of masseter muscle hypertrophy. J Oral Maxill Surg. 2005; 63: 20–24.
Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res. 2018 Mar 16; 11:571-587. doi: 10.2147/JPR.S127950. PMID: 29588615; PMCID: PMC5859913.
Christidis, N., Al-Moraissi, E. A., Barjandi, G., Svedenlöf, J., Jasim, H., Christidis, M., & Collin, M. Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis. Drugs. 2024; 84(1): 59–81. https://doi.org/10.1007/s40265-023-01971-9
von Lindern JJ, Niederhagen B, Bergé S, Appel T. Type A botulinum toxin in the treatment of chronic facial painassociated with masticatory hyperactivity. J Oral Maxillofac Surg. 2003; 61: 774–778.
Kurtoglu, C., Gur, O. H., Kurkcu, M., Sertdemir, Y., Guler-Uysal, F., & Uysal, H. (2008). Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. Journal of oral and maxillofacial surgery. 2008; 66(8), 1644–1651.
https://doi.org/10.1016/j.joms.2008.03.008
Patel D, Mehta F, Trivedi R, Thakkar S, Suthar J. Botulinum toxin and gummy smile – A review. IOSR J Dent Med Sci. 2013;4:1–5.
Batifol, D., Huart, A., Finiels, P. J., Nagot, N., & Jammet, P. (2018). Effect of intra-articular Botulinum toxin injections on temporo-mandibular joint pain. Journal of stomatology, oral and maxillofacial surgery. 2018;119(4): 319–324. https://doi.org/10.1016/j.jormas.2018.06.002
Yoshida K. Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity. Toxins. 2018; 10(5):174. https://doi.org/10.3390/toxins10050174
de-la-Hoz, J. L., de-Pedro, M., Martín-Fontelles, I., Mesa-Jimenez, J., Chivato, T., & Bagües, A. Efficacy of botulinum toxin type A in the management of masticatory myofascial pain: A retrospective clinical study. The Journal of the American Dental Association, 2022; 153(7): 683-691.
Ramos-Herrada RM, Arriola-Guillén LE, Atoche-Socola KJ, Bellini-Pereira SA, Castillo AA. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review. Dent Med Probl. 2022 Apr-Jun;59(2):271-280. doi: 10.17219/dmp/145759. PMID: 35775414.
Villa S, Raoul G, Machuron F, Ferri J, Nicot R. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder. J Stomatol Oral Maxillofac Surg. 2019 Feb;120(1):2-6. doi: 10.1016/j.jormas.2018.10.007. Epub 2018 Oct 29. PMID: 30385428.
Matak I. Evidence for central antispastic effect of botulinum toxin type A. Br J Pharmacol. 2020 Jan;177(1):65-76. doi: 10.1111/bph.14846. Epub 2019 Nov 6. PMID: 31444910; PMCID: PMC6976784.
William G. Ondo, Christine Hunter, Warren Moore. double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology.2004; 62 (1): 37-40. DOI: 10.1212/01.WNL.0000101713.81253.4C
Vargas H, Galati LT, Parnes SM. A Pilot Study Evaluating the Treatment of Postparotidectomy Sialoceles with Botulinum Toxin Type A. Arch Otolaryngol Head Neck Surg. 2000;126(3):421–424. doi:10.1001/archotol.126.3.421
Minakuchi, H., Fujisawa, M., Abe, Y., Iida, T., Oki, K., Okura, K., Tanabe, N., & Nishiyama, A. (2022). Managements of sleep bruxism in adult: A systematic review. The Japanese dental science review. 2022; 58: 124–136. https://doi.org/10.1016/j.jdsr.2022.02.004
Cerón, L., Pacheco, M., Delgado Gaete, A., Bravo Torres, W., & Astudillo Rubio, D. (2023). Therapies for sleep bruxism in dentistry: A critical evaluation of systematic reviews. Dental and medical problems. 2023; 60(2): 335–344. https://doi.org/10.17219/dmp/156400
Rojo-Sanchis, C., Montiel-Company, J. M., Tarazona-Álvarez, B., Haas-Junior, O. L., Peiró-Guijarro, M. A., Paredes-Gallardo, V., & Guijarro-Martínez, R. (2023). Non-Surgical Management of the Gingival Smile with Botulinum Toxin A-A Systematic Review and Meta-Analysis. Journal of clinical medicine. 2023; 12(4): 1433. https://doi.org/10.3390/jcm12041433
Kayani, A. M. A., Silva, M. S., Jayasinghe, M., Singhal, M., Karnakoti, S., Jain, S., & Jena, R. (2022). Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia. Cureus. 2022; 14(7): e26856. https://doi.org/10.7759/cureus.26856
Ban, A., Roman, R., Bran, S., Băciuț, M., Dinu, C., Crasnean, E., Almășan, O., & Hedeșiu, M. (2023). Botulinum Toxin Injection into the Digastric Muscle: Current Clinical Use and a Report of Five Cases. Biomedicines. 2023; 11(10): 2767. https://doi.org/10.3390/biomedicines11102767
Archana MS. Toxin yet not toxic: Botulinum toxin in dentistry. Saudi Dent J. 2016 Apr;28(2):63-9. doi: 10.1016/j.sdentj.2015.08.002. Epub 2015 Dec 21. PMID: 27486290; PMCID: PMC4957535.
